The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Plasma Adiponectin Levels Are Associated with Insulin Resistance, But Do Not Predict Future Risk of Coronary Heart Disease in Women
Abstract
CONTEXT: Low adiponectin levels predict type 2 diabetes, and one prospective study in men reported its independent prediction of vascular events. Many observers thus already consider adiponectin to be a major part of the "common soil" underpinning diabetes and vascular disease. OBJECTIVE: The objective of this study was to assess the association between adiponectin and incident coronary heart disease (CHD) risk in the British Women's Heart and Health Study. DESIGN: This was a prospective (4 yr) case (n = 167) control (n = 334) study nested within the 4286 women in British Women's Heart and Health Study. SETTING: The study was performed in a primary care setting. PARTICIPANTS: The study consisted of women (n = 4286) randomly selected from 23 British towns between 1999 and 2001, who were 60-79 yr of age at baseline. MAIN OUTCOME MEASURES: Association of adiponectin with CHD risk factors and incident CHD events were the main outcome measures. RESULTS: Among both cases and controls, adiponectin positively correlated with age and high-density lipoprotein cholesterol and inversely correlated with waist to hip ratio, fasting insulin, fasting glucose, homeostasis model assessment of insulin resistance scores, C-reactive protein, and triglycerides. However, despite adequate power and these associations with CHD risk factors, adiponectin did not predict CHD events in unadjusted or adjusted analyses. The relative risk ratio for a doubling of adiponectin was 0.93 (95% confidence interval, 0.78, 1.11). CONCLUSIONS: It is premature to consider adiponectin as a root for vascular disease in women despite its association with insulin resistance and diabetes. Additional prospective studies are required to determine whether there is a true sex difference in the effect of adiponectin on CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Self-citationHavel, P. J. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00008 · Cited by 575
Lee, W. L., Cheung, A. M., Cape, D., & Zinman, B. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.962 · Cited by 442 · cited 2×
“The relative effects of diabetes and hyperglycemia on CHD are greater in women compared with men (18).”
BackgroundAdiponectin and Coronary Heart Disease: The Strong Heart Study
Lindsay, R. S., Resnick, H. E., Zhu, J., Tun, M. L., Howard, B. V., Zhang, Y., Yeh, J., & Best, L. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000153090.21990.8c · Cited by 169 · cited 3×
“The lack of an association with CHD risk is consistent with one previous prospective study of American Indian men and women (17), but not with a prospective”
BackgroundResult
Cited by
Adiponectin as an anti-inflammatory factor
Ouchi, N., & Walsh, K. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.026 · Cited by 872
Fuster, J. J., Ouchi, N., Gokce, N., & Walsh, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306885 · Cited by 664
Adiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631
Leptin and Cardiovascular Disease: Response to Therapeutic Interventions
Koh, K. K., Park, S. M., & Quon, M. J. (2008) · Circulation · doi:10.1161/circulationaha.107.741645 · Cited by 479
Adiponectin: a key adipocytokine in metabolic syndrome
Okamoto, Y., Kihara, S., Funahashi, T., Matsuzawa, Y., & Libby, P. (2006) · Clinical Science · doi:10.1042/cs20050182 · Cited by 432
Adiponectin and Coronary Heart Disease: A Prospective Study and Meta-Analysis
Sattar, N., Wannamethee, G., Sarwar, N., Tchernova, J., Cherry, L., Wallace, A. M., Danesh, J., & Whincup, P. H. (2006) · Circulation · doi:10.1161/circulationaha.106.618918 · Cited by 403
Self-citationAdiponectin actions in the cardiovascular system
HOPKINS, T., OUCHI, N., SHIBATA, R., & WALSH, K. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.009 · Cited by 327
Cardiac Energy Metabolism in Obesity
Lopaschuk, G. D., Folmes, C. D. L., & Stanley, W. C. (2007) · Circulation Research · doi:10.1161/circresaha.107.150417 · Cited by 307
Adiponectin and Mortality in Patients with Chronic Kidney Disease
Menon, V., Li, L., Wang, X., Greene, T., Balakrishnan, V., Madero, M., Pereira, A. A., Beck, G. J., Kusek, J. W., Collins, A. J., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040331 · Cited by 283
Adiponectin and Cardiovascular Disease
Han, S. H., Quon, M. J., Kim, J.-A., & Koh, K. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.061 · Cited by 276
Frystyk, J., Berne, C., Berglund, L., Jensevik, K., Flyvbjerg, A., & Zethelius, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1067 · Cited by 201
von Eynatten, M., Hamann, A., Twardella, D., Nawroth, P. P., Brenner, H., & Rothenbacher, D. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.060509 · Cited by 140
Hao, G., Li, W., Guo, R., Yang, J.-G., Wang, Y., Tian, Y., Liu, M.-Y., Peng, Y.-G., & Wang, Z.-W. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.018 · Cited by 82
“Excluding 1 study [24]with 4 years of follow-up duration, the overall risk estimate changed only slightly (RR: 1.”
BackgroundInfluentialSerum Adiponectin and Coronary Heart Disease Risk in Older Black and White Americans
Kanaya, A. M., Wassel Fyr, C., Vittinghoff, E., Havel, P. J., Cesari, M., Nicklas, B., Harris, T., Newman, A. B., Satterfield, S., Cummings, S. R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0107 · Cited by 71
Liu, Y., Vu, V., & Sweeney, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00842 · Cited by 69
Effects of sleep restriction on adiponectin levels in healthy men and women
Simpson, N. S., Banks, S., Arroyo, S., & Dinges, D. F. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.08.006 · Cited by 46
Metadata
- Authors
- Lawlor, D. A., Davey Smith, G., Ebrahim, S., Thompson, C., & Sattar, N.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-10
- Volume
- 90
- Issue
- 10
- Pages
- 5677-5683
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1998552802
- Cited by
- 219
- References
- 5
- FWCI
- 18.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.